LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.93 | 27.76 | 824 | 4421 | 0.1864 | 0.5896 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.93 | 27.76 | 67 | 4421 | 0.0152 | 0.1280 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.93 | 27.76 | 1052 | 4421 | 0.2379 | 0.6436 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.63 | 27.76 | 77 | 4818 | 0.0160 | 0.1470 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.63 | 27.76 | 890 | 4818 | 0.1847 | 0.5938 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.63 | 27.76 | 78 | 4818 | 0.0162 | 0.1490 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.63 | 27.76 | 1096 | 4818 | 0.2275 | 0.6390 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.33 | 27.76 | 70 | 5117 | 0.0137 | 0.1308 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.33 | 27.76 | 889 | 5117 | 0.1737 | 0.5850 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.33 | 27.76 | 79 | 5117 | 0.0154 | 0.1491 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.33 | 27.76 | 1063 | 5117 | 0.2077 | 0.6231 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.04 | 27.76 | 79 | 5365 | 0.0147 | 0.1477 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.04 | 27.76 | 900 | 5365 | 0.1677 | 0.5810 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.04 | 27.76 | 80 | 5365 | 0.0149 | 0.1496 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.04 | 27.76 | 1039 | 5365 | 0.1936 | 0.6112 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.74 | 27.76 | 83 | 5606 | 0.0148 | 0.1538 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.74 | 27.76 | 893 | 5606 | 0.1593 | 0.5734 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.74 | 27.76 | 85 | 5606 | 0.0152 | 0.1574 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.74 | 27.76 | 1028 | 5606 | 0.1834 | 0.6026 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.45 | 27.76 | 88 | 5745 | 0.0153 | 0.1618 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.45 | 27.76 | 861 | 5745 | 0.1499 | 0.5627 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.45 | 27.76 | 68 | 5745 | 0.0118 | 0.1235 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.45 | 27.76 | 1062 | 5745 | 0.1848 | 0.6059 | MN20160318_Q01 | I20 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.15 | 27.76 | 96 | 5906 | 0.0163 | 0.1740 | MN20160318_Q01 | H15 |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.15 | 27.76 | 877 | 5906 | 0.1485 | 0.5629 | MN20160318_Q01 | H15 |